EDGAR Filing Documents for 0001437749-15-018932

Form 8-K - Current report:

SEC Accession No. 0001437749-15-018932

Filing Date

2015-10-27

Accepted

2015-10-27 17:24:54

Documents

Period of Report

2015-10-22

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	nby20151026_8k.htm	8-K	36030
2	EXHIBIT 1.1	ex1-1.htm	EX-1.1	227743
3	EXHIBIT 4.1	ex4-1.htm	EX-4.1	110690
4	EXHIBIT 4.2	ex4-2.htm	EX-4.2	131018
5	EXHIBIT 4.3	ex4-3.htm	EX-4.3	122810
6	EXHIBIT 4.4	ex4-4.htm	EX-4.4	106542
7	EXHIBIT 5.1	ex5-1.htm	EX-5.1	15349
8	EXHIBIT 99.1	ex99-1.htm	EX-99.1	14029
9	EXHIBIT 99.2	ex99-2.htm	EX-99.2	12541
10		spb_logo.jpg	GRAPHIC	5540
	Complete submission text file	0001437749-15-018932.txt		785748

Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608

Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 (510) 899-8800

NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)